Diagnostics Pipeline: To Gain Insight into Haystack MRD Test, Quest Works with City of Hope
New liquid biopsy assay will be used in conjunction with 500 cancer patients currently enrolled in clinical trials
Already a member? Log in here
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Quest Diagnostics Launches Consumer-Facing AI on Its App and Portal
The company’s patients can use AI to look at trends going back five years
Already a member? Log in here
Thermo Fisher Scientific Debuts Pharmacogenetic Test to Improve Transplant Safety
Proper dosing helps prevent potential side effects such as developing diabetes and kidney damage
Already a member? Log in here
GRAIL’s Moves with MCED Test Illustrate Direct-to-Consumer Surge
By partnering with Hims & Hers and Epic, GRAIL bypasses traditional lab test arrangement
Already a member? Log in here
GNPC identifies subset of proteins elevated across Alzheimer’s and Parkinson’s
Consortium hosts large proteomics dataset for neurodegenerative diseases
Already a member? Log in here
Quest Introduces Myeloma Test That Eliminates the Need for Bone Marrow Biopsies
The flow cytometry assay costs a fraction of traditional invasive bone marrow testing
Already a member? Log in here
ClearNote Health Launches Early Detection Test for Pancreatic Cancer
The test offers a 76 percent sensitivity to detection of stage 1 and stage 2 pancreatic cancers
Already a member? Log in here
Turning Physics into a Diagnostic Signal for Bladder Cancer
A physics-based urine test shows early promise in detecting bladder cancer recurrence without invasive procedures
Already a member? Log in here
Diagnostics Pipeline: NeuroQure Launches Test for Early Autism Diagnosis
The skin-based test can be used on children as young as two days old
Already a member? Log in here
How Labs Can Lead in Early Detection of Infectious Diseases
Smarter operations, automation, and collaboration can strengthen laboratories’ role in early detection
Already a member? Log in here
AI-Designed Molecular Sensors Could Transform Early Cancer Detection
Advances could signal changes for clinical laboratories and at-home testing
Already a member? Log in here
Rise of Capillary Electrophoresis in the Clinical Laboratory
The technology has moved from niche to practical for routine diagnostics
Already a member? Log in here
Diagnostics Pipeline: MyOme and Artera Launch New Tests for Prostate Cancer Risk
The two assays identify threats prior to prostate cancer being diagnosed and after it has undergone extensive treatment, respectively
Already a member? Log in here
